Literature DB >> 27319606

Soluble TREM-1 as a diagnostic and prognostic biomarker in patients with septic shock: an observational clinical study.

Thorsten Brenner1, Florian Uhle1, Thomas Fleming2, Matthias Wieland1, Thomas Schmoch1, Felix Schmitt1, Karsten Schmidt1, Aleksandar R Zivkovic1, Thomas Bruckner3, Markus A Weigand1, Stefan Hofer1.   

Abstract

OBJECTIVES: The impact of TREM-1-mediated inflammation was investigated in different inflammatory settings.
METHODS: Secondary analyses of an observational clinical pilot study, including 60 patients with septic shock, 30 postoperative controls and 30 healthy volunteers.
RESULTS: Plasma levels of sTREM-1 were found to identify patients with septic shock more effectively than procalcitonin and C-reactive protein. Moreover, sTREM-1 was identified to be an early predictor for survival in patients with septic shock.
CONCLUSION: Due to its diagnostic as well as prognostic value in sepsis syndrome, implementation of sTREM-1 measurements in routine diagnostics should be taken into account.

Entities:  

Keywords:  (soluble) triggering receptor expressed on myeloid cells; Diagnosis; prognosis; sepsis; septic shock; severe sepsis

Mesh:

Substances:

Year:  2016        PMID: 27319606     DOI: 10.1080/1354750X.2016.1204005

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  20 in total

1.  Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.

Authors:  Danielle Ahn; Alice Prince
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 2.  Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis.

Authors:  Courtney P Rudick; David L Cornell; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2017-07-28       Impact factor: 4.473

Review 3.  TREM-1 Modulation Strategies for Sepsis.

Authors:  Sara Siskind; Max Brenner; Ping Wang
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

4.  Identification of Extracellular Actin As a Ligand for Triggering Receptor Expressed on Myeloid Cells-1 Signaling.

Authors:  Lei Fu; Li Han; Caiyun Xie; Wenke Li; Lan Lin; Shan Pan; You Zhou; Zhi Li; Meilin Jin; Anding Zhang
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

Review 5.  Neutrophil dysregulation during sepsis: an overview and update.

Authors:  Xiao-Fei Shen; Ke Cao; Jin-Peng Jiang; Wen-Xian Guan; Jun-Feng Du
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

6.  Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.

Authors:  Monika Jedynak; Andrzej Siemiatkowski; Barbara Mroczko; Magdalena Groblewska; Robert Milewski; Maciej Szmitkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-12-27       Impact factor: 4.291

Review 7.  Triggering Receptor Expressed on Myeloid Cells-1 Signaling: Protective and Pathogenic Roles on Streptococcal Toxic-Shock-Like Syndrome Caused by Streptococcus suis.

Authors:  Li Han; Lei Fu; Yongbo Peng; Anding Zhang
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

8.  Effect of Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Blockade in Rats with Cecal Ligation and Puncture (CLP)-Induced Sepsis.

Authors:  Xiaofeng Shi; Yue Zhang; Hao Wang; Sha Zeng
Journal:  Med Sci Monit       Date:  2017-10-23

Review 9.  Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids.

Authors:  Tom Vanden Berghe; Eric Hoste
Journal:  Cell Death Differ       Date:  2018-09-10       Impact factor: 15.828

10.  Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial.

Authors:  Bruno Francois; Simon Lambden; Sebastien Gibot; Marc Derive; Aurelie Olivier; Valerie Cuvier; Stephan Witte; Jean-Marie Grouin; Jean Jacques Garaud; Margarita Salcedo-Magguilli; Mitchell Levy; Pierre-François Laterre
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.